A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH)
Clinical trial NCT03496207 · COMPLETED
Trial details
- NCT number
- NCT03496207
- Sponsor
- Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-13
- Primary completion
- 2022-03-09
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.